Journals / Eurasian Journal of Medical Investigation / 2021 / Cilt: 5 - Sayı: 3

The Effects of Arteriovenous Fistulas (AVF) on Patients’ Cardiacand Endothelial Function in Renal Transplant Recipients

Pages
295–300
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In the brachial artery FMD analysis,when the group with open AVF was compared with the group with AVF closed, the FMD values of the group with openAVF were found to be statistically significantly lower (p=0.023).Conclusion: The study concluded that while there was no significant effect of AVF on left ventricular hypertrophy, itwas associated with endothelial dysfunction.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: This was a cross-sectional study to demonstrate the effects of AVFs in renal transplant recipients on cardiacand endothelial functions of patients.Methods: The patients were evaluated in three groups including working AVF, closing AVF, and never opening AVF.LVM and LVMI values were calculated from echocardiographic measurements.
📊
Key Findings & Data:Brachial artery FMD (flow- mediated vas cular dilation) measurements of 81 patients were performed using the high-resolution external B-mode USG method.At the end of two years, the LVM and LVMI values of 45 patients, were calculated from echocardiographic measure ments and compared with baseline findings.
💡
Conclusion & Impact:In the brachial artery FMD analysis,when the group with open AVF was compared with the group with AVF closed, the FMD values of the group with openAVF were found to be statistically significantly lower (p=0.023).Conclusion: The study concluded that while there was no significant effect of AVF on left ventricular hypertrophy, itwas associated with endothelial dysfunction.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: This was a cross-sectional study to demonstrate the effects of AVFs in renal transplant recipients on cardiacand endothelial functions of patients.Methods: The patients were evaluated in three groups including working AVF, closing AVF, and never opening AVF.LVM and LVMI values were calculated from echocardiographic measurements. Brachial artery FMD (flow- mediated vas cular dilation) measurements of 81 patients were performed using the high-resolution external B-mode USG method.At the end of two years, the LVM and LVMI values of 45 patients, were calculated from echocardiographic measure ments and compared with baseline findings. Results: In the group with open AVF, it was observed that LVM (244±72 [g]) to 222±56 [g], p=0.039) and LVMI (139±31[g/m2 ] to 123±27 [g/m2 ], p=0.002) values decreased significantly after two years. In the brachial artery FMD analysis,when the group with open AVF was compared with the group with AVF closed, the FMD values of the group with openAVF were found to be statistically significantly lower (p=0.023).Conclusion: The study concluded that while there was no significant effect of AVF on left ventricular hypertrophy, itwas associated with endothelial dysfunction.

🔖

Cite This Article

TÜRKMEN, A., BESİROĞLU, M. (2022). The Effects of Arteriovenous Fistulas (AVF) on Patients’ Cardiacand Endothelial Function in Renal Transplant Recipients. Eurasian Journal of Medical Investigation, Cilt: 5 - Sayı: 3, 295–300. https://ajindex.com/articles/508557

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Rao NN, Stokes MB, Rajwani A, Ullah S, Williams K, King D, et al. Effects of arteriovenous fistula ligation on cardiac structure and function in kidney transplant recipients. Circulation 2019
  2. 2809–18. [CrossRef] 2. Burra P, De Bona M. Quality of life following organ transplantation. Transpl Int 2007
  3. 397–409. [CrossRef] 3. Pascual M, Theruvath T, Kawai T, Tolkoff-Rubin N, Cosimi AB. Strategies to improve long-term outcomes after renal transplantation. N Engl J Med 2002
  4. 580–90. [CrossRef] 4. Hernández D. Left ventricular hypertrophy after renal transplantation: new approach to a deadly disorder. Nephrol Dial Transplant 2004
  5. 1682–6. [CrossRef] 5. de Simone G, Pasanisi F, Contaldo F. Link of nonhemodynamic factors to hemodynamic determinants of left ventricular hypertrophy. Hypertension 2001
  6. 13–8. [CrossRef] 6. de Simone G, Palmieri V. Left ventricular hypertrophy in hypertension as a predictor of coronary events: relation to geometry. Curr Opin Nephrol Hypertens 2002
  7. 215–20. [CrossRef] 7. Foley RN, Parfrey PS, Harnett JD, Kent GM, Martin CJ, Murray DC, et al. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int 1995
  8. 186–92. [CrossRef] 8. McGregor E, Stewart G, Rodger RS, Jardine AG. Early echocardiographic changes and survival following renal transplantation. Nephrol Dial Transplant 2000
  9. 93–8. [CrossRef] 9. Unger P, Velez-Roa S, Wissing KM, Hoang AD, van de Borne P. Regression of left ventricular hypertrophy after arteriovenous fistula closure in renal transplant recipients: a long-term follow-up. Am J Transplant 2004
  10. 2038–44. [CrossRef] 10. Buemi M, Senatore M, Gallo GC, Crasci E, Campo S, Sturiale A, et al. Pulmonary hypertension and erythropoietin. Kidney Blood Press Res 2007
  11. 248–52. [CrossRef] 11. Cridlig J, Selton-Suty C, Alla F, Chodek A, Pruna A, Kessler M, et al. Cardiac impact of the arteriovenous fistula after kidney transplantation: a case-controlled, match-paired study. Transpl Int 2008
  12. 948–54. [CrossRef] 12. Schofield I, Malik R, Izzard A, Austin C, Heagerty A. Vascular structural and functional changes in type 2 diabetes mellitus: evidence for the roles of abnormal myogenic responsiveness and dyslipidemia. Circulation 2002
  13. 3037–43. [CrossRef] 13. Celermajer DS. Testing endothelial function using ultrasound. J Cardiovasc Pharmacol. 1998
  14. 32 Suppl 3:S29–32. 14. Aakhus S, Dahl K, Widerøe TE. Cardiovascular morbidity and risk factors in renal transp